scispace - formally typeset
Search or ask a question

At what age early breast cancer is diagnosed? 


Best insight from top research papers

Early breast cancer is typically diagnosed in patients aged 40 years and younger, with a median age at diagnosis reported to be around 36 years . However, studies have shown that early breast cancer patients can also be older, with a mean age at diagnosis of 51.2 years and 55.9% of patients being aged 50 years or older . Additionally, a study categorized patients into different age groups, with group Y aged ≤35 years, group M aged >35 and ≤45 years, and group E aged >45 years, showing that very young age (≤35 years) did not independently predict poor prognosis in early-stage breast cancer . Therefore, early breast cancer can be diagnosed across a wide age range, but the median and mean ages reported in the studies suggest that it is often diagnosed in younger individuals.

Answers from top 5 papers

More filters
Papers (5)Insight
Early breast cancer is diagnosed in patients aged 40 years and younger, with a median age of 36 years at diagnosis, as reported in the study.
Early-stage breast cancer can affect women aged 24 to >70 years, with a study dividing patients into groups Y (≤35 years), M (>35 and ≤45 years), and E (>45 years).
Early breast cancer is typically diagnosed around the age of 51.2 years, with 55.9% of patients being aged 50 years or older at diagnosis, as per the study.
Early breast cancer is diagnosed at age 40 through early mammography screening, leading to significantly lower incidence rates after 3-, 5-, and 10-year follow-ups compared to on-time screening at age 50.
Early breast cancer is diagnosed in patients aged 40 years and younger, with a median age of 36 years reported in the study.

Related Questions

How common is early breast cancer?5 answersEarly-onset breast cancer (EOBC) accounts for a significant proportion of breast cancer cases, with studies showing that approximately 20.2% of diagnosed cases are EOBCs, while 79.8% are late-onset breast cancers (LOBCs). Breast cancer is a prevalent issue globally, affecting millions of women each year and being a leading cause of cancer-related deaths among women. In developing countries, up to 20% of breast cancer cases occur in women younger than 40 years, often presenting as aggressive and high-grade tumors with poor survival rates. Detecting breast cancer early is crucial for improving survival rates, with strategies like early diagnosis and screening being essential. The high incidence of breast cancer has led to the implementation of screening programs, emphasizing the importance of early detection for better outcomes.
What are the traditional screening methods of breast cancer for early detection?5 answersTraditional screening methods for early detection of breast cancer include mammography, clinical and self-breast examinations, genetic screening, ultrasound, and magnetic resonance imaging. These methods aim to detect the disease before symptoms like a palpable lump appear, allowing for early intervention and treatment. Additionally, recent advancements have introduced innovative approaches such as biosensors, microwave imaging techniques, and infrared thermography combined with laser interference microscopy for early breast cancer diagnosis. Research also suggests the potential of utilizing microRNAs and gene expressions of circulating tumor cells in blood plasma for early detection through machine learning models and artificial neural networks. Moreover, cutting-edge technologies like measuring temperature differentials in breast tissue using electromagnetic radiation have shown promise in detecting cancerous tissue within the breast.
Why is it important to diagnose and screen for breast cancer early?5 answersEarly diagnosis and screening for breast cancer are important because they can significantly improve the chances of survival and reduce treatment costs. Early detection allows for timely initiation of treatment, which is more effective and less expensive. Screening programs for breast cancer have been recommended and applied worldwide, including in China, to reduce mortality rates. However, the benefits of screening have been a topic of debate, with some studies suggesting that the effectiveness may vary depending on the type of cancer being screened. Artificial intelligence techniques, such as convolutional neural networks and machine learning algorithms, have shown promise in early breast cancer diagnosis, providing reliable results and the potential for widespread accessibility. These advancements in technology can aid in the early detection of breast cancer, leading to improved outcomes for patients.
At what age does breast cancer decrease?10 answers
Does early detection of breast cancer equate to successful treatment?6 answers
What is the average age for a woman to be diagnosed with osteoporosis?3 answers

See what other people are reading

What is the acceptance of clinicians of AI in TB detection?
5 answers
Clinicians have shown a positive acceptance of Artificial Intelligence (AI) in tuberculosis (TB) detection. Studies have demonstrated the utility of AI-based systems in TB diagnosis. AI models have been developed using machine learning approaches to predict adverse effects and mortality after TB treatment, providing valuable tools for clinicians. Additionally, AI-powered platforms have been successfully utilized to screen and prioritize at-risk patients for pulmonary TB based on cough sound analysis, showcasing high accuracy, sensitivity, and specificity. The incorporation of AI in TB detection has shown promising results, offering clinicians a reliable and efficient means to detect TB early and predict adverse outcomes, ultimately enhancing patient care and treatment outcomes.
Why Using CFA Should Use Sample Size 10-Times Rule?
5 answers
The use of the 10-times rule for sample size in Confirmatory Factor Analysis (CFA) is crucial due to its impact on statistical power and precision of parameter estimates. Adequate sample size is essential to ensure the accuracy and reliability of CFA results, as smaller sample sizes can lead to underpowered analyses and inaccurate model fit assessments. While traditional rules of thumb like the minimum R2 and ten-time rule may generate sample sizes that are too small for PLS-SEM studies, adhering to the 10-times rule helps in achieving the necessary statistical power (0.80) to avoid false results. Therefore, following the 10-times rule for sample size in CFA is recommended to enhance the robustness and validity of the analysis results.
How disability influences health among old?
5 answers
Disability significantly impacts the health of the elderly population, leading to increased mortality rates. Studies highlight that disability, especially in activities of daily living (ADL), is closely linked to health shocks and decreased quality of life among the elderly. The presence of impairments and disabilities in the elderly population, particularly those with chronic diseases, elevates the risk of all-cause mortality. Moreover, individuals with disabilities experience premature aging, facing challenges such as chronic pain, musculoskeletal complications, and late effects that exacerbate existing disabilities as they age. Addressing disability in the elderly requires a comprehensive approach considering the complex interplay between aging, disabilities, and chronic health conditions to ensure optimal health outcomes and quality of life.
What is the importance of predicting patient outcomes in cancer treatment ?
5 answers
Predicting patient outcomes in cancer treatment is crucial for personalized therapy. By utilizing real-world data and statistical frameworks, individualized estimates of treatment efficacy and toxicity can be obtained, aiding clinicians in making informed decisions. Additionally, analyzing patient-reported outcomes (PROs) dynamically can serve as early predictors of treatment response, potentially improving response rates and adapting treatments effectively. Artificial intelligence (AI) and machine learning (ML) applications further enhance outcome prediction by providing accurate risk assessment, early diagnosis, prognosis estimation, and treatment selection. These predictive tools not only improve healthcare accuracy but also have the potential to enhance patient outcomes across various cancers, emphasizing the importance of individualized and data-driven care in cancer treatment.
What predicts success as a startup founder?
5 answers
The success of a startup founder can be predicted by various factors identified in the research papers. Factors such as the period from foundation to the first financing, the area of activity, type, and amount of the first financing round, business model, and applied technologies play crucial roles in predicting startup success. Additionally, critical success factors identified through a systematic method and a hybrid model can significantly contribute to predicting the success of a startup in information technology, with precision and accuracy improvements observed through machine learning algorithms. Moreover, the combination of human intuition and machine capabilities in a Hybrid Intelligence method has been proposed to predict startup success under extreme uncertainty, highlighting the importance of leveraging both human and machine strengths for accurate predictions.
Is wnt7b an oncogene in cancer?
4 answers
Yes, WNT7B has been implicated as an oncogene in cancer. Research has shown that WNT7B is overexpressed in certain cancer types, such as oral squamous cell carcinoma (OSCC) and lung squamous cell carcinoma (LUSC). The overexpression of WNT7B has been linked to promoting cancer cell invasion and contributing to the development of oral chronic inflammation and OSCC. Additionally, WNT7B knockdown has been shown to reduce cell proliferation and invasion ability in OSCC cells, further supporting its role as an oncogene in cancer. These findings suggest that WNT7B plays a significant role in tumorigenesis and could be a potential target for therapeutic interventions in pan-tissue-type originated tumors.
If a mcular hoe close spontanously is there a chance for reccurrence?
4 answers
In the case of a macular hole closing spontaneously, there is a possibility of recurrence, especially in the context of various medical conditions. For instance, in patients with malignant germ cell tumors, close monitoring for at least 5 years post-initial treatment is crucial to detect any recurrences or second tumors early. Similarly, in breast cancer patients undergoing breast-conservation surgery, factors like age younger than 50 years and omission of radiotherapy are associated with increased local recurrence rates, emphasizing the importance of vigilant follow-up and appropriate treatment strategies. Moreover, supportive close telephone follow-up has been shown to significantly improve Helicobacter pylori eradication success rates, indicating the positive impact of monitoring and intervention in preventing recurrences. Therefore, regular monitoring and timely intervention are essential to address any potential recurrence following the spontaneous closure of a macular hole.
What is the gradient boosting algorithm?
5 answers
The gradient boosting algorithm is a powerful machine learning technique that sequentially fits new models to improve the accuracy of predicting the response variable. It involves constructing base learners highly correlated with the negative gradient of the loss function for the entire ensemble. Gradient boosting, particularly XGBoost, has shown exceptional predictive capabilities and versatility in various applications, including medical diagnostics, breast tissue pathology assessment, and predicting agent-based model outputs. XGBoost is known for its efficiency in modeling complex systems, incorporating machine learning algorithms, and providing high prediction accuracy. By utilizing gradient boosting, researchers have achieved significant advancements in predictive modeling, accuracy, and computational efficiency across diverse fields, making it a widely used and effective algorithm in machine learning applications.
How does the prevalence of COVID-19 vaccine uptake in Nigeria compare to other African countries?
5 answers
The prevalence of COVID-19 vaccine uptake in Nigeria varies compared to other African countries. In Nigeria, studies have shown varying rates of vaccine uptake among different groups. For instance, among health workers in Ebonyi state, the uptake was 68.2%, with 47.4% fully vaccinated and 20.9% partially vaccinated. On the other hand, a study on Nigerian households found that only 32.8% of respondents were vaccinated against COVID-19, with factors like age, education level, and information sources influencing uptake. In comparison to other African countries, a meta-analysis revealed an overall vaccine acceptance rate of 71.0% in Africa, with variations by region and demographic factors such as age, sex, and wealth influencing acceptance rates. These findings highlight the need for targeted strategies to improve vaccine uptake in Nigeria and across Africa.
What is Common signals of drug safety?
5 answers
Common signals of drug safety include adverse events detected through various sources like spontaneous reporting systems, clinical studies, and scientific literature. These signals are crucial for post-marketing pharmacovigilance to identify potential adverse drug reactions that were not evident during clinical trials. Safety signals can arise from multiple sources such as spontaneous reports, clinical trials, meta-analyses, case reports, and large databases like the Sentinel initiative by the USFDA. Factors that contribute to the identification of significant signals requiring regulatory actions, such as product information updates, include evidence from multiple data sources, mechanistic plausibility of the drug-event association, seriousness of the event, and the age of the drug being ≤5 years. These characteristics play a vital role in prioritizing signals for further investigation and necessary regulatory interventions.
What is the risk of venous infarction?
5 answers
The risk of venous infarction varies depending on the specific surgical procedure or medical condition. For instance, the supracerebellar infratentorial approach (SCITA) carries a risk of cerebellar venous infarction, estimated at 0.345% based on case series analysis. Postoperative cerebral venous infarction after meningioma resection was found in 4.7% of cases, with identified risk factors including tumor location and severity of peritumoral edema. Additionally, venous thromboembolism (VTE) poses risks of recurrent VTE, sudden cardiac death, and high mortality rates, with various predisposing factors such as inactivity, smoking, and malignancy. Furthermore, after VTE, there is an increased risk of major adverse cardiovascular events (MACE) and major adverse limb events (MALE), with identified risk factors including age, VTE characteristics, and comorbidities.